๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Clarithromycin - Medicines in Ireland

21 authorised products containing Clarithromycin, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 21 authorised medicines
MedicineActive substanceLicence holderStatus
Clarithromycin 250 mg film-coated tablets
PA2315/197/001
Clarithromycin Accord Healthcare Ireland Ltd. Marketed
Clarithromycin 250 mg film-coated tablets
PA2050/002/001
Clarithromycin Sun Pharmaceutical Industries Europe B.V. Marketed
Clarithromycin 500 mg film-coated tablets
PA2315/197/002
Clarithromycin Accord Healthcare Ireland Ltd. Marketed
Clarithromycin 500 mg film-coated tablets
PA2050/002/002
Clarithromycin Sun Pharmaceutical Industries Europe B.V. Marketed
Clarithromycin 500 mg powder for concentrate for solution for infusion
PA2237/003/001
Clarithromycin hameln pharma gmbh Not marketed
Clarithromycin 500 mg Powder for Concentrate for Solution for Infusion
PA1142/022/001
Clarithromycin Amdipharm Limited Marketed
Clarithromycin Krka 250 mg film-coated tablets
PA1347/068/001
Clarithromycin KRKA, d.d., Novo mesto Not marketed
Clarithromycin Krka 500 mg film-coated tablets
PA1347/068/002
Clarithromycin KRKA, d.d., Novo mesto Not marketed
Clarithromycin Teva 250 mg film-coated tablets
PA0749/148/001
Clarithromycin Teva Pharma B.V. Marketed
Clarithromycin Teva 500 mg film-coated tablets
PA0749/148/002
Clarithromycin Teva Pharma B.V. Marketed
Clonocid 250 mg film-coated Tablets
PA0126/136/001
Clarithromycin Clonmel Healthcare Ltd Marketed
Clonocid 500 mg film-coated tablets
PA0126/136/002
Clarithromycin Clonmel Healthcare Ltd Marketed
Clorom 250 mg Film-Coated Tablets
PA0711/061/001
Clarithromycin Rowex Limited, Marketed
Clorom 500 mg film-coated tablets
PA0711/061/002
Clarithromycin Rowex Limited, Marketed
Clorom XL 500 mg Prolonged-Release Tablets
PA23142/006/001
Clarithromycin Aspire Pharma (Malta) Limited Marketed
Klacid 250 mg film-coated tablets
PA23355/013/001
Clarithromycin Viatris Healthcare Limited Marketed
Klacid 250 mg/5 ml Granules for Oral Suspension
PA23355/013/006
Clarithromycin Viatris Healthcare Limited Marketed
Klacid Forte 500 mg film-coated tablets
PA23355/013/002
Clarithromycin Viatris Healthcare Limited Marketed
Klacid IV 500mg Powder for Concentrate for Solution for Infusion
PA23355/013/003
Clarithromycin Viatris Healthcare Limited Marketed
Klacid LA 500mg Modified release tablets
PA23355/013/004
Clarithromycin Viatris Healthcare Limited Marketed
Klacid Paediatric Suspension 125 mg/5 ml, Granules for Oral Suspension
PA23355/013/005
Clarithromycin Viatris Healthcare Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.